Craving Network Neurofeedback
Yale University · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT06426693
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–60 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- November 27, 2024
- Record last updated
- December 3, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This project tests whether individuals with overweight or obesity and high craving can learn to change their brain response to food cues using neurofeedback, to impact their craving and eating behavior.
Being studied: Experimental feedback; Control feedback
Conditions: Overweight or Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Ages 18 to 60 years
- Body mass index >25 kg/m2
- >2.37 Food Craving Inventory score
Exclusion Criteria
- Current or past 6 months use of anti-obesity medications
- Weight-reduced state defined as >10% weight reduction in the past 6 months.
- Nicotine use
- Current diagnosis of neurological or psychiatric disorder
- Obesity-related diseases such as type-2 diabetes
- Contraindications to MRI
- Baseline scanning with motion >0.15mm frame to frame displacement.
Recruiting US locations
Yale MRRC Anlyan Center
New Haven, CT 06519
Study contacts (from the official record)
- Kathleen A Garrison, PhD · 2037376232 · kathleen.garrison@yale.edu
Similar studies in Connecticut
All weight loss studies in Connecticut →- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Waterbury, CT + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Hoffmann-La Roche
- Location
- New Haven, CT + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Regeneron Pharmaceuticals
- Location
- Waterbury, CT + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Eli Lilly and Company
- Location
- Bridgeport, CT + 59 other US sites
- Eligibility basics
- Ages 18+